KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Invested Capital (2016 - 2025)

Historic Invested Capital for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $1.1 billion.

  • AbbVie's Invested Capital fell 8577.62% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 8577.62%. This contributed to the annual value of $70.5 billion for FY2024, which is 104.04% up from last year.
  • Per AbbVie's latest filing, its Invested Capital stood at $1.1 billion for Q3 2025, which was down 8577.62% from $1.9 billion recorded in Q2 2025.
  • In the past 5 years, AbbVie's Invested Capital ranged from a high of $92.1 billion in Q4 2021 and a low of $1.1 billion during Q3 2025
  • Over the past 5 years, AbbVie's median Invested Capital value was $19.4 billion (recorded in 2024), while the average stood at $29.3 billion.
  • In the last 5 years, AbbVie's Invested Capital surged by 78518.72% in 2021 and then crashed by 9040.55% in 2025.
  • Quarter analysis of 5 years shows AbbVie's Invested Capital stood at $92.1 billion in 2021, then fell by 12.54% to $80.6 billion in 2022, then decreased by 13.38% to $69.8 billion in 2023, then increased by 1.04% to $70.5 billion in 2024, then tumbled by 98.37% to $1.1 billion in 2025.
  • Its Invested Capital was $1.1 billion in Q3 2025, compared to $1.9 billion in Q2 2025 and $5.2 billion in Q1 2025.